Home > Drug Search >
  • company_query: Beijing Zhongyuan Hengkang Biotechnology
  •   > 
Drug Filter
Category:
chemistry (36) biology (29)
Status:
Approved (14) BLA Filing (1) Phase Ⅲ (8) Phase Ⅱ (21) Phase Ⅰ (21)
Clinical Stage:
Pending (4) Active (36) Discontinued (11)
Bio-Type:
Gene therapy (1) Vaccine (2) Blood extraction (6) Recombinant coagulation factor (2) Recombinant hormone (1) Bispecific antibody (1) Single-chain FV antibody fragment (scFv) (1) Whole antibody (9) Fusion protein (2)
Indication:
Acute myeloid Leukemia (AML) (1) Alzheimer's disease (AD) (1) Atrial fibrillation (1) Bladder cancer (1) Breast cancer (6) Guillain-Barre syndrome (1) Mucocutaneous lymph node syndrome (Kawasaki syndrome) (1) Colorectal neoplasms (1) Crohn's disease (2) Cushing's disease (1) Diabetic macular edema (1) Eye disorders (1) Gastric cancer (2) HBV infection (3) Hepatocellular carcinoma (HCC) (1) Pediatric plaque psoriasis (1) Huntington's disease (1) Hypercholesterolemia (1) Hyperparathyroidism (1) Ischaemia (1) Hepatitis A viral infection (1) Haemolytic disease of the newborn (1) Chronic inflammatory demyelinating polyradiculoneuropathy (1) Rabies (1) Afibrinogenaemia (1) Lung cancer (1) Malignancies (1) Melanoma (2) Non small cell lung cancer (NSCLC) (10) Non-alcoholic fatty liver disease (NAFLD) (1) Obesity (1) Osteoarthritis (OA) (1) Ovarian cancer (5) Pancreatic cancer (9) Parkinson's disease (PD) (1) Postmenopausal osteoporosis (1) Postoperative pain (1) Prostate cancer (6) Tetanus (1) Psoriasis (3) Psoriatic arthritis (3) Rheumatoid arthritis (RA) (7) Varicella zoster virus infections (1) Small cell lung cancer (SCLC) (3) Solid tumours (7) Systemic lupus erythematosus (2) Type 2 diabetes (5) Ulcerative colitis (2) Uveitis (1) Amyloid polyneuropathy (1) Colorectal cancer (3) Ankylosing Spondylitis (AS) (3) Spondyloarthritis (2) Homozygous familial hypercholesterolemia (1) Pediatric Crohn’s disease (2) Hidradenitis suppurativa (1) Type 1 diabetes (1) Hemophilia A (2) Hemophilia B (2) Renal carcinoma (2) Contraception (1) Hereditary angioedema (HAE) (2) Spinal muscular atrophy (1) Congenital factor XIII A-subunit deficiency (1) Esophagus cancer (1) Plaque psoriasis (2) Allergic asthma (1) Bleeding (2) Skin hypertrophic scars (1) Lipodystrophy (1) Liver cancer (1) Immunodeficiency disorders (1) Alpha-1 antitrypsin deficiency (1) Inflammatory pain (1) Juvenile idiopathic arthritis (JIA) (1) Immune thrombocytopenic purpura (1)
Country:
Aprv. Year:
 (1) 2013 (1) 2015 (1) 2016 (4) 2017 (2)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 4 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top